// App-Quantinova.ai

3233 : Combination Of Lenalidomide, Dexamethasone and Cyclophosphamide as Treatment For The First Relapse Of Multiple Myeloma: Efficacy, Toxicity and Occurance Of Thyroid Abnormalities

Researchers

Presenter

  • Marta Krejci

Principal Investigators

  • Zdenek Adam

  • Ludek Pour

  • Jana Pelcova

  • Jiri Mayer

Medical Centers

  • Dpt. of Internal Medicine, Hematology and Oncology, UNIVERSITY HOSPITAL BRNO, Brno, Czech Republic

  • Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic

  • Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic

  • University Hospital Brno, Brno, Czech Republic

Locations

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hypothyroidism

  • Multiple Myeloma

  • Thrombocytopenia

  • Constipation

  • Neutropenia

  • Peripheral neuropathy

  • Venous thrombosis

  • Anemia

Biomarkers

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved